Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
PLIANT THERAPEUTICS, INC. (PLRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 13,069 shares
@ $20, valued at
$261.4k
Sold 1,800 shares
@ $20, valued at
$36k
Sold 20,050 shares
@ $20.01, valued at
$401.2k
Exercised 1,800 options to buy
@ $2.08, valued at
$3.7k
Exercised 8,791 options to buy
@ $2.08, valued at
$18.3k
|
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 27,187 shares
@ $0 |
|
| 07/18/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 43,750 shares
@ $0 |
|
| 07/18/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 35,156 shares
@ $0 |
|
| 07/18/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 38,750 shares
@ $0 |
|
| 07/18/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 137,500 shares
@ $0 |
|
| 06/12/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Exercised 5,800 options to buy
@ $2.08, valued at
$12.1k
|
|
| 06/08/2023 |
4
| Shah Smital (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| MCCOURT Thomas A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Knobil Katharine (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Cline Darren S (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 04/03/2023 |
4
| Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 4,874 shares
@ $26.5209, valued at
$129.3k
Sold 2,677 shares
@ $26.7371, valued at
$71.6k
Sold 200 shares
@ $27.455, valued at
$5.5k
|
|
| 04/03/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 11,245 shares
@ $26.5209, valued at
$298.2k
|
|
| 04/03/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 9,036 shares
@ $26.5209, valued at
$239.6k
|
|
| 04/03/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 9,960 shares
@ $26.5209, valued at
$264.1k
|
|
| 04/03/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 35,339 shares
@ $26.5209, valued at
$937.2k
|
|
| 03/31/2023 |
4
| Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 13,593 shares
@ $0 |
|
| 03/31/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 21,874 shares
@ $0 |
|
| 03/31/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 17,578 shares
@ $0 |
|
| 03/31/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 19,375 shares
@ $0 |
|
| 03/31/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 68,749 shares
@ $0 |
|
| 03/08/2023 |
4
| MCCOURT Thomas A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 22,000 options to buy
@ $31.11, valued at
$684.4k
|
|
| 03/08/2023 |
4
| Cline Darren S (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 22,000 options to buy
@ $31.11, valued at
$684.4k
|
|
|
|
|